Navigation Links
Roots of polycystic ovarian syndrome traced to mother’s wom

How the daughters develop in their mother’s womb can be an indication of how they may be at risk// from developing polycystic ovarian syndrome.

Polycystic ovarian syndrome is a condition that affects about 10% of the women in the childbearing age. This condition is characterized by high levels of male hormones called androgens, with irregular or no menstrual cycles, and with presence or absence of small cysts in their ovaries. The syndrome may affect the women’s health and cause problems in menstrual cycle and fertility, hormonal imbalance, insulin production, cardiovascular problems, and physical appearance.

Researchers from University of Adelaide, Australia, had reported at the 21st annual conference of the European Society of Human Reproduction and Embryology that pregnancy and childbirth can unleash several factors in female fetus that can affect the incidence and intensity of polycystic ovarian syndrome when they grow to their adulthood.

Researchers suggest that several developmental pathways affecting the fetus may be responsible for the incidence of polycystic ovarian syndrome in daughters later in life. One such pathway may be the incidence of high maternal bodyweight in late pregnancy that can lead to irregular periods in daughter. This may in turn lead to daughters being overweight and have other weight related problems. Like this there are other developmental pathways that may get affected enough to cause polycystic ovarian syndrome in daughters in their adult life.

Reference: European Society of Human Reproduction and Embryology, news release, June 2005 , polycystic ovarian syndrome, mother’s womb, pregnancy and childbirth, female fetus, high maternal bodyweight, developmental pathways, androgens, irregular or no menstrual cyces
'"/>




Page: 1

Related medicine news :

1. Mad Cow Disease Has Roots Traceable To Man
2. Parkinsons Disease Has Genetic Roots
3. Scientists Trace the Roots of the Worlds Healthiest Wines
4. Hypertension Has Its Roots in Childhood
5. Progestin protects against ovarian cancer
6. Inherited gene important in ovarian cancer
7. Blood test may identify ovarian cancer
8. Screening device for ovarian cancer
9. Ethnic discrepancy in ovarian cancer
10. Associated scan for detecting ovarian cancer spread
11. New medicine for ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... IN (PRWEB) , ... February 10, 2016 , ... ... benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its growing ... has seven other locations throughout the Southeast, from Orlando to Huntsville and in ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... the country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA ... volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... ... Workrite Ergonomics this week announced the launch of the Conform Monitor Arm Series, ... was to develop a product from the ground up that would provide the most ... Hulsey, Product Manager for Workrite Ergonomics. “The Conform series features a wide variety ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... BASEL, Switzerland and SAN DIEGO ... Houston , Inc., a global leader in viral gene ... gene therapy treatments for congestive heart failure and other ... to develop a scalable manufacturing process and produce cGMP-grade ... clinical trials. --> ...
(Date:2/10/2016)... Immune Pharmaceuticals Inc. (NASDAQ: IMNP ), ... has filed a patent application directed to the treatment ... --> --> The new invention ... (histamine dihydrochloride) in combination with immune checkpoint inhibitors. The ... of Ceplene and IL-2 therapy in patients with Acute ...
(Date:2/10/2016)... ANGELES , Feb. 10, 2016  Oxis International ... cancer drug, OXS-1550, was described as a "clinical trial ... the drug went into complete cancer remission. ... University of Minnesota Masonic Cancer Center. --> ... University of Minnesota Masonic Cancer Center. --> ...
Breaking Medicine Technology: